A study published in JAMA Network Open found that people with type 2 diabetes who take Ozempic, may have a lower risk of developing certain obesity-related cancers. We spoke with Dr. Maryam Lustberg, Medical Oncologist and Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, about the news.
Image Credit: Reuters